Etamsylate (Hemostat Inj (250mg)) is a haemostatic agent, prescribed for the management of blood loss in menorrhagia, and after surgery.It reduces bleeding from very small blood vessels (capillaries).

"We are excited to expand our global partnership with EndoClot Plus, Inc. The addition of their solutions to our portfolio allows us to strengthen our commitment to our customers as a full ...

As outlined in their recent publication in Biomaterials Science, researchers from the Terasaki Institute for Biomedical Innovation, (TIBI), have developed an injectable, temperature-sensitive, ...

Based on EndoClot AMP Technology, Submucosal Injection Solution (SIS) and Polysaccharide Hemostatic Spray (PHS) Systems Assist with Submucosal Lift and Hemostasis During GI Procedures "Anything we can ...

A novel hemostatic sealant based on the in situ gel formation of gelatin catalyzed by thrombin and crosslinked by transglutaminase was designed. The aim of this study was to investigate the efficacy ...

The EndoClot portfolio supports hemostasis and lifting in endoscopic submucosal dissection or resection during gastrointestinal procedures HAMBURG, Germany, April 20, 2023 /PRNewswire/ -- Olympus ...